Specialty Pharmacy

CTL019 is an investigational chimeric antigen receptor T cell therapy.

The CEO of the Cutaneous Lymphoma Foundation describes the challenges of living with the disease.

Sarilumab (Kevzara) is a humanized monoclonal antibody that treats moderate-to-severe active RA.

Study explores the impact of tumor mutation burden and PD-L1 status in immunotherapy response.

The guidelines aim to reduce the risk of infection in patients administered anti-rheumatic medication.

Top news of the day from across the health care landscape.

More than 1.1 million Americans are HIV-positive, yet 15% are unaware of their status.

The new tool aims to help patients make more informed treatment decisions and manage expectations following a cancer diagnosis.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, explores the benefits of incorporating specialty pharmacists into care teams.

The tool can help reduce the cost of treatment for rheumatoid arthritis.

Top news of the day from across the health care landscape.

Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.

Investigational drug demonstrates a substantial and clinically meaningful reduction in bleeds related to hemophilia.

The National HIV Testing Day annual campaign takes place on June 27th.

Data suggests favorable tolerability of novel treatment in patients with relapsed or refractory AML.

Rational design approaches could transform how multiple sclerosis is treated.

Top news of the day from across the health care landscape.

Adding an investigational diabetes drug to anti-cancer regimen may reduce cardiotoxicity.

CT-P10 is indicated to treat a form of non-Hodgkin lymphoma and rheumatoid arthritis.

A Complete Response Letter cited issues related to violations within a McPherson, KS, facility.

The presence of a specific protein is crucial to balance the immune system in the gut.

Differences in major risk factors and inequalities in health care access have resulted in substantial disparities in liver cancer mortality.

The guideline reinforces stereotactic body radiation therapy as the standard of care for medically inoperable patients with non-small cell lung cancer.

Scientists solve protein structures to reveal new treatment developments for diseases such as Ebola virus, Lyme disease, and tuberculosis .

Getting too much or too little sleep can elevate the risk of cancer.

Top news of the day from across the health care landscape.

Targeting KRAS mutations may lead to effective new pancreatic cancer treatments.

New analysis examines opioid use among patients with rheumatoid arthritis.